InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	VISIOMED GROUP LIMITED (VSG)
Date of Listing:	01 June 1987
Date of Delisting:	05 March 2008
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 05 March 2008.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

VISIOMED GROUP LIMITED(VSG)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
XCELL DIAGNOSTICS LIMITED	02/08/2001	24/09/2003
FIMISTON RESOURCES AND TECHNOLOGY LIMITED	24/05/2000	02/08/2001
FIMISTON MINING NL	06/06/1995	24/05/2000
FIMISTON MINING LIMITED	07/05/1987	06/06/1995
BOORARA MINING LIMITED		07/05/1987

Shareholder links

REGISTRY:

110 Stirling Hwy, Nedlands WA 6009

Tel : +61 8 9389 8033
Fax : +61 8 9262 3723
RegistryWebsite RegistryEmail

Company details

Address: Level 1 , 173 Mounts Bay Road , PERTH , WA, AUSTRALIA, 6000
Tel: (08) 9321 2712 Fax: (08) 9485 0602

Date first listed: 01/06/1987
Company Secretary:
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Development and marketing of products for paediatric inhalant medication delivery

News & Events

Expand this box to read and print

delisted following completion of schemes of arrangement between the Company and its shareholders and optionholders in respect to the acquisition of the Company by Clinical Cell Culture Limited	05/03/2008
we understand that under the merger of Visiomed Group Limited (Visiomed) and Clinical Cell Culture Limited (Clinical Cell) Visiomed shareholders received five (5) Clinical Cell New Shares for every seven (7) Visiomed Shares they held and Visiomed optionholders received five (5) Clinical Cell New Options for every seven (7) Visiomed Options they held - resulting in Visiomed Shareholders owning approximately 54% of the Merged Group and Clinical Cell Shareholders owning approximately 46% of the Merged Group	05/03/2008
Clinical Cell Culture Ltd announces that it has finalised the acquisition and merger with Visiomed Group Limited	27/02/2008
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - merger with Clinical Cell Culture Ltd - this corporate event may appear elsewhere in this company record	21/02/2008
Visiomed Group Limited confirms that the court order approving the schemes of arrangement between Visiomed and its share and option holders has been lodged with the Australian Securities and Investments Commission - The record date for determining entitlements to Clinical Cell Culture Limited shares and options will be 21 February 2008, and it is expected that holding statements and certificates for Clinical Cell Shares and Options will be despatched on approximately 27 February 200	14/02/2008
securities suspended from quotation following receipt of approval for the schemes of arrangement	13/02/2008
shares reinstated to quotation	06/10/2006
securities suspended from quotation at the request of the company	04/10/2006
shares reinstated to quotation	30/11/2005
releases a copy of the presentation that was made to shareholders at the AGM by the CEO and advises that the two resolutions were passed	29/11/2005
shares suspended from quotation pending release of an announcement	28/11/2005
name changed from Xcell Diagnostics Limited	24/09/2003

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Ian Macpherson	Chairman, Non Exec Director
William Dolphin	CEO
Saliba Sassine	Non Exec Director
Dalton Gooding	Non Exec Director
Paul Watt	Non Exec Director
Dennis Thiele	General Manager
Graeme Boden	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.